MBrace Therapeutics

MBrace Therapeutics is a clinical-stage pharmaceutical company developing anti-tumor monoclonal human recombinant antibodies for the treatment of cancer patients. The company utilizes technology to develop antibody-drug conjugates that target specific cancer cells and release toxic drugs into them, enabling healthcare professionals to better target cancer cells.